Kate Lewis, Pharmacy PreceptorSpecialty Pharmacy Supervisor

Rotations Precepted

  • PGY1 Ambulatory - staffing preceptor
  • CPGY1 - Specialty Pharmacy rotation
  • PGY1 Acute Care - Specialty Pharmacy elective rotation
  • PGY2 Oncology - Specialty Pharmacy elective rotation
  • PGY2 Administration - Specialty Pharmacy rotation

Pharmacy Schools

  • University of Wisconsin-Madison, 2003, BS - Chemistry, Spanish
  • University of Illinois-Chicago, 2007, PharmD
  • University of Wisconsin- Milwaukee, 2023, MHA

Residency Training Programs

  • Froedtert Hospital: Acute Care PGY1 Froedtert Hospital (2007- 2008)
  • Froedtert Hospital: PGY2 Health System Pharmacy Administration (2008- 2009)

Professional Interests

Specialty Pharmacy, Limited Distribution Drugs (LDD), Oncology, Research, Pharmacy Education

Organizational Involvement

  • American Society of Health System Pharmacists (ASHP)
    • Section of Specialty Pharmacy Practitioners (SSPP)
      • Accreditation and Compliance Section Advisory Group (SAG) 2022-2023
    • Section of Specialty Pharmacy Practitioners (SSPP)
      • Accreditation and Compliance Section Advisory Group (SAG) 2023-2024
  • Pharmacy Society of Wisconsin (PSW) Member
  • Vanderbilt Health System Specialty Pharmacy Outcomes Research Member
  • Acentrus Specialty Limited Distribution Drug (LDD) Committee
  • National Association of Specialty Pharmacy (NASP) Member

Awards and Certifications

  • APhA: Pharmacy-Based Immunization Delivery UIC; 2006
  • Teaching Certificate: UW-Madison; 2008
  • Board Certified Pharmacotherapy Specialist (2015)

Publications

  • Kelly T, Kumor L, Lewis K, Miller C, Nugent R, and Yoon R. Specialty Pharmacy Accreditation and Compliance Position FTE Justification. ASHP Podcasts. 2023. Accessed July 23, 2023.
  • Zuckerman A, DeClercq J, Choi L, Cowgill N, McCarthy K, Lounsbery B, Shah R, Kehasse A, Thomas K, Sokos L, Stutsky M, Young J, Carter J, Lach M, Wise K, Thomas T, Ortega M, Lee J, Lewis K, Dura J, Gazda N, Gerzenshtein L, Canfield S. Adherence to self- administered biologic disease-modifying antirheumatic drugs across health- system specialty pharmacies. Am J Health Syst Pharm. 2021 Aug 18; doi: 10.1093/ajhp/zxab342.

Projects

  • Nelson K, Smith H, Meyer D, Ninomiya J. The impact of multimodal pre-emptive and analgesic analgesia on concomitant opioids use, length of stay, and post operative pain control in orthopedic patients undergoing knee replacements. (July 2007- June 2008)
  • Nelson K, Newkirk G, Theesfeld M, Karpinski T, Peplinski R, Klauk, J. Design and Implementation of a Pharmacy Department Scorecard. (June 2008-July 2009)
  • Hanson A, Hoefing E, Urmanski A, Busse K, Lewis K. Medication history and concomitant medication review in early- phase, oral, investigational, anticancer, clinical trials: pharmacist consult service. (August 2014- June 2015)
  • Fraser B, Hoefing E, Urmanski A, Busse K, Lewis K. Assessment of compliance with outpatient Beacon Treatment Plan Update Requests for Patients Currently Receiving Investigational Therapies. (July 2015- June 2016)
  • Pella B, Lewis K, Hoefing E, Busse K, Urmanski A, Hanson K. Enhancing the clinical pharmacist’s ability to manage patients enrolled in a clinical trial. (July 2016- September 2017)
  • Shumate A, Zook F, Canadeo A, Lorge A, Lewis K. Development and Implementation of a Blinatumomab Monitoring Guideline and Collaborative Practice Agreement to Improve Safety and Transitions of Care. (July 2017- June 2018)
  • Koppinger S, Ternes L, Lewis K, et al. Pharmacist-Driven Tacrolimus Dosing and Monitoring in Kidney Transplant Patients. (July 2020- June 2021)
  • Lewis K, Cha- Vang K, Hinz R, Papi L, McClendon J, Graff P, McCaughey R. Froedtert Specialty Pharmacy “Lite” Program. (July 2020- September 2021)
  • Pariri, M, Lewis, K, Katzfuss, A, Skudlarczyk, J. “Pharmacist impact on adherence to laboratory monitoring and provider follow-up for HIV PrEP patients participating in a medication management program affiliated with a health- system specialty pharmacy.” (July 2021- June 2022)
  • Lewis K, Kneip B, Zywicke J, Cha- Vang K, Hinz R, Johnson J, Carter D, Bachar A, Thomas K, Ward A, Wise S. “Specialty Pharmacy Lite- Phase 2.”(July 2022- June 2023)
  • Wessel C, Glennon B, Dalton H, Thomas K, Lewis K, Hinkley T, Fraser S, Elder T. “Implementation of Medication Synchronization within a Home Delivery and Specialty Pharmacy.” (July 2022- June 2023)
  • Lewis K, Brandau L, Hoang H, Schmitz S, Glennon B, Goetz B, Johnson J, Modi K, Thomas K, Cha- Vang K. “Analysis of Medication Therapy Management Services Workflow Optimization.” (July 2022- June 2023)
  • Zuckerman A, Tong K, Thomas K, Whelchel K, Gosser R, Kehasse A, McCarthy K, Plaia G, Cha A, Lewis K, Loucks J, Platt T. “Safety Screening in Patients Initiating Biologic Specialty Medications.” (April 2022 – September 2023)

Hobbies

Traveling, walking, attending Dance Mom events, and relaxing at the lake house.

Favorite Milwaukee Pastimes

Tailgating at Brewers and UW- Madison games.

What is your favorite clinical trial?

My favorite clinical trial is the E1910 study. Froedtert participated and enrolled several patients. I enjoyed being a member of the project research team. It was a complex clinical trial (28 Epic Beacon builds, 72 hour IV bag changes, etc.) but the study results have demonstrated the patients’ increased overall survival with the addition of blinatumomab to the chemotherapy consolidation regimen.